Steven Kroon (S Kroon)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Patient Reported Outcomes

Ejection Fraction

Advanced Non Small Cell Lung Cancer

Top Venues

Journal of clinical medicine

Vascular medicine (London, England)

European heart journal. Cardiovascular Imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Josefien Hessels, Steven Kroon, Sanne Boerman, Rik C Nelissen, Jan C Grutters, Repke J Snijder, Franck Lebrin, Marco C Post, Christine L Mummery, Johannes-Jurgen Mager
Efficacy and Safety of Tacrolimus as Treatment for Bleeding Caused by Hereditary Hemorrhagic Telangiectasia: An Open-Label, Pilot Study. Journal of clinical medicine 11 (18) (2022)
Steven Kroon, Mitch C J Van Thor, Veerle M M Vorselaars, Anna E Hosman, Martin J Swaans, Repke J Snijder, Hans-Jurgen Mager, Marco C Post
The use of echo density to quantify pulmonary right-to-left shunt in transthoracic contrast echocardiography. European heart journal. Cardiovascular Imaging 22 (10) (2021)
Steven Kroon, Veronique Mm Vorselaars, Anna E Hosman, Martijn C Post, Repke J Snijder, Johannes J Mager
Prevalence and diagnostic value of nail fold capillary microscopy in hereditary hemorrhagic telangiectasia: A retrospective study. Vascular medicine (London, England) 25 (4) (2020)
Els M de Gussem, Steven Kroon, Anna E Hosman, Johannes C Kelder, Martijn C Post, Repke J Snijder, Johannes J Mager
Hereditary Hemorrhagic Telangiectasia (HHT) and Survival: The Importance of Systematic Screening and Treatment in HHT Centers of Excellence. Journal of clinical medicine 9 (11) (2020)
Steven Kroon, R J Snijder, A E Hosman, V M M Vorselaars, F J M Disch, M C Post, J J Mager
Oral itraconazole for epistaxis in hereditary hemorrhagic telangiectasia: a proof of concept study. Angiogenesis 24 (2) (2020)